Ledger.Open graph →

SEC Form D · filed September 27, 2017

APRICUS BIOSCIENCES, INC

Offering

$3.7M

Sold

$3.7M

Exemption

Rule 506(c)

Industry

Pharmaceuticals

Location

SAN DIEGO, CA

Type

—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (16)

Daniel Hershberg · Blue Bell, PADirector Charles Thomas · Grand Cayman, Cayman IslandsDirector Brandon M. Miller · Dallas, TXDirector Kevin Regan · Somers, CTDirector Kent T. Marquardt · Palo Alto, CAExec Webb M. Sowden · Dallas, TXExec Peter Fineberg · Blue Bell, PADirector Peter D'Amato · Woodbury, CTExec · Director Scott Schroeder · Chicago, ILExec Campbell M. Wilson · Charlotte, NCDirector Arjun Peruvemba · Randolph, NJDirector Samir Kaul · Cambridge, MADirector Sammy Khalifa · Cambridge, MADirector Dror Berman · Cambridge, MAExec Timothy Kirkwood · Aspen, COExec · Director Waters Kellogg · Aspen, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗